Promoting Diversity in Clinical Trial Leadership: A Call to Action.
Publication
, Journal Article
Lindenfeld, J; Fiuzat, M; O'Connor, C
Published in: JACC Heart Fail
May 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
May 2021
Volume
9
Issue
5
Start / End Page
401 / 402
Location
United States
Related Subject Headings
- Leadership
- Humans
- Heart Failure
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lindenfeld, J., Fiuzat, M., & O’Connor, C. (2021). Promoting Diversity in Clinical Trial Leadership: A Call to Action. JACC Heart Fail, 9(5), 401–402. https://doi.org/10.1016/j.jchf.2021.03.005
Lindenfeld, JoAnn, Mona Fiuzat, and Christopher O’Connor. “Promoting Diversity in Clinical Trial Leadership: A Call to Action.” JACC Heart Fail 9, no. 5 (May 2021): 401–2. https://doi.org/10.1016/j.jchf.2021.03.005.
Lindenfeld J, Fiuzat M, O’Connor C. Promoting Diversity in Clinical Trial Leadership: A Call to Action. JACC Heart Fail. 2021 May;9(5):401–2.
Lindenfeld, JoAnn, et al. “Promoting Diversity in Clinical Trial Leadership: A Call to Action.” JACC Heart Fail, vol. 9, no. 5, May 2021, pp. 401–02. Pubmed, doi:10.1016/j.jchf.2021.03.005.
Lindenfeld J, Fiuzat M, O’Connor C. Promoting Diversity in Clinical Trial Leadership: A Call to Action. JACC Heart Fail. 2021 May;9(5):401–402.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
May 2021
Volume
9
Issue
5
Start / End Page
401 / 402
Location
United States
Related Subject Headings
- Leadership
- Humans
- Heart Failure
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology